المؤلفون: Adeline Gasser, PhD, Yu-Wen Chen, MD, PhD, Anais Audebrand, MSci, Ayhan Daglayan, MSci, Marine Charavin, PhD, Brigitte Escoubet, MD, PhD, Pavel Karpov, PhD, Igor Tetko, PhD, Michael W.Y. Chan, PhD, Daniela Cardinale, MD, PhD, Laurent Désaubry, PhD, Canan G. Nebigil, PharmD, PhD

المصدر: JACC. CardioOncology, Vol 1, Iss 1, Pp 84-102 (2019)

مصطلحات موضوعية: breast cancer, doxorubicin, endothelial dysfunction, epicardial progenitor cells, heart failure, Diseases of the circulatory (Cardiovascular) system, RC666-701, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2666087319300043Test; https://doaj.org/toc/2666-0873Test

الوصول الحر: https://doaj.org/article/084a7eda97e34e36bf013fb6c4afb797Test

المؤلفون: Anais Audebrand, Laurent Désaubry, Canan G. Nebigil

المصدر: Frontiers in Cardiovascular Medicine, Vol 6 (2020)

مصطلحات موضوعية: GPCRs, cardiotoxicity, melatonin, ghrelin, galanin, apelin, Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/article/10.3389/fcvm.2019.00194/fullTest; https://doaj.org/toc/2297-055XTest

الوصول الحر: https://doaj.org/article/8b66bc79a5cc4fc5b8061529cd5cbeceTest

المؤلفون: Gaël Nicolas, Myriam Sévigny, François Lecoquierre, Florent Marguet, Andréanne Deschênes, Maria Carment del Pelaez, Sébastien Feuillette, Anaïs Audebrand, Magalie Lecourtois, Stéphane Rousseau, Anne-Claire Richard, Kévin Cassinari, Vincent Deramecourt, Charles Duyckaerts, Anne Boland, Jean-François Deleuze, Vincent Meyer, Jordi Clarimon Echavarria, Ellen Gelpi, Haruhiko Akiyama, Masato Hasegawa, Ito Kawakami, Tsz H. Wong, Jeroen G. J. Van Rooij, John C. Van Swieten, Dominique Campion, Paul A. Dutchak, David Wallon, Flavie Lavoie-Cardinal, Annie Laquerrière, Anne Rovelet-Lecrux, Chantelle F. Sephton

المصدر: Acta Neuropathologica Communications, Vol 10, Iss 1, Pp 1-18 (2022)

مصطلحات موضوعية: FUS (fused in sarcoma), Frontotemporal dementia (FTD), NCDN (neurochondrin), Norbin, Genetic variant, De novo mutation, Neurology. Diseases of the nervous system, RC346-429

العلاقة: https://doi.org/10.1186/s40478-022-01314-xTest; https://doaj.org/toc/2051-5960Test; https://doaj.org/article/48e521d609984a38b72e92aa11f8c79bTest

الإتاحة: https://doi.org/10.1186/s40478-022-01314-xTest
https://doaj.org/article/48e521d609984a38b72e92aa11f8c79bTest

المؤلفون: Brigitte Escoubet, Laurent Désaubry, Adeline Gasser, Marine Charavin, Michael W. Y. Chan, Anais Audebrand, Daniela Cardinale, Pavel Karpov, Canan G. Nebigil, Igor V. Tetko, Ayhan Daglayan, Yu-Wen Chen

المساهمون: Laboratoire de Cardio-Oncologie et Chimie Médicinale, Centre National de la Recherche Scientifique (CNRS), Institute of Biomedical sciences, Academia Sinica, Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université de Paris (UP), Nanomédecine Régénérative (NanoRegMed), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Biotechnologie et signalisation cellulaire (BSC), Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-Institut de recherche de l'Ecole de biotechnologie de Strasbourg (IREBS), Laboratoire d'Innovation Thérapeutique (LIT), Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche des Cordeliers (CRC (UMR_S 872)), Université Paris Descartes - Paris 5 (UPD5)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institute of Structural Biology (Neuherberg), Helmholtz-Zentrum München (HZM), European Institute of Oncology [Milan] (ESMO), Tianjin University of Science and Technology (TUST), Laboratoire des biomolécules (LBM UMR 7203), Institut National de la Santé et de la Recherche Médicale (INSERM)-Chimie Moléculaire de Paris Centre (FR 2769), Université Pierre et Marie Curie - Paris 6 (UPMC)-Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Ecole Nationale Supérieure de Chimie de Paris - Chimie ParisTech-PSL (ENSCP), Université Paris sciences et lettres (PSL)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris sciences et lettres (PSL)-Département de Chimie - ENS Paris, École normale supérieure - Paris (ENS Paris), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Neuroheuristic Research Group, ISI Foundation, European Institute of Oncology, Chimie Moléculaire de Paris Centre (FR 2769), Université Pierre et Marie Curie - Paris 6 (UPMC)-ESPCI ParisTech-Ecole Nationale Supérieure de Chimie de Paris- Chimie ParisTech-PSL (ENSCP)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Paris (ENS Paris)-Université Pierre et Marie Curie - Paris 6 (UPMC)-ESPCI ParisTech-Ecole Nationale Supérieure de Chimie de Paris- Chimie ParisTech-PSL (ENSCP)-Centre National de la Recherche Scientifique (CNRS)-École normale supérieure - Paris (ENS Paris)-Département de Chimie - ENS Paris, École normale supérieure - Paris (ENS Paris)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)

المصدر: JACC. CardioOncology, Vol 1, Iss 1, Pp 84-102 (2019)
JACC: CardioOncology
JACC: CardioOncology, Elsevier, 2019, 1 (1), pp.84-102. ⟨10.1016/j.jaccao.2019.06.003⟩
JACC CardioOncology
JACC CardioOncology, 2019, 1 (1), pp.84-102. ⟨10.1016/j.jaccao.2019.06.003⟩

مصطلحات موضوعية: lcsh:Diseases of the circulatory (Cardiovascular) system, PKR1-KO, prokineticin receptor 1 knockout mice, [SDV]Life Sciences [q-bio], Aucun, heart failure, 030204 cardiovascular system & hematology, Pharmacology, DMSO, dimethyl sulfoxide, HF, heart failure, endothelial dysfunction, 0302 clinical medicine, polycyclic compounds, Medicine, Endothelial dysfunction, NRF2, nuclear factor, erythroid 2 like 2 (also known as NFE2L2), PKR1, prokineticin receptor-1 (also known as PROKR1), ComputingMilieux_MISCELLANEOUS, Original Research, 0303 health sciences, FS, fractional shortening, epicardial progenitor cells, food and beverages, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prokineticin, 3. Good health, Oncology, Cardiology and Cardiovascular Medicine, PROK1, prokineticin 1, medicine.drug, Cardiovascular toxicity, GPCR, G-protein–coupled receptor, Anthracycline, [SDV.CAN]Life Sciences [q-bio]/Cancer, HAEC, human aortic endothelial cell, doxorubicin, lcsh:RC254-282, 03 medical and health sciences, Breast cancer, breast cancer, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, EF, ejection fraction, Doxorubicin, HFrEF, heart failure with reduced ejection fraction, 030304 developmental biology, business.industry, EC, endothelial cell, PROK2, prokineticin 2, Prokineticin receptor 1, PECAM, platelet and endothelial cell adhesion molecule, medicine.disease, lcsh:RC666-701, Heart failure, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, EDPC, epicardium-derived progenitor cell, business, MAPK, mitogen-activated protein kinase, TUNEL, terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deb816b6ed59e9b54a853d3cf450c545Test
http://www.sciencedirect.com/science/article/pii/S2666087319300043Test

المؤلفون: Anais Audebrand, Canan G. Nebigil, Ayca Toprak-Semiz, Kyoji Urayama, Marja Steenman, Ferda Demir, Hitoshi Kurose

المساهمون: Nanomédecine Régénérative (NanoRegMed), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Advanced Telecommunications Research Institute International (ATR), unité de recherche de l'institut du thorax UMR1087 UMR6291 (ITX), Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Kyushu University [Fukuoka], Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN), Unité de recherche de l'institut du thorax (ITX-lab), Kyushu University, NEBIGIL Desaubry, Canan, univOAK, Archive ouverte

المصدر: Hypertension
Hypertension, American Heart Association, 2021, 77 (5), pp.1559-1570. ⟨10.1161/HYPERTENSIONAHA.120.16808⟩
Hypertension, American Heart Association, 2021, 77 (5), ⟨10.1161/HYPERTENSIONAHA.120.16808⟩
Hypertension, 2021, 77 (5), pp.1559-1570. ⟨10.1161/HYPERTENSIONAHA.120.16808⟩
Hypertension, 2021, 77 (5), ⟨10.1161/HYPERTENSIONAHA.120.16808⟩

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, [SDV.OT]Life Sciences [q-bio]/Other [q-bio.OT], medicine.medical_treatment, [SDV]Life Sciences [q-bio], heart failure, Cardiomegaly, Mice, Transgenic, [SDV.BC]Life Sciences [q-bio]/Cellular Biology, 030204 cardiovascular system & hematology, Muscle hypertrophy, Gastrointestinal Hormones, 03 medical and health sciences, Mice, 0302 clinical medicine, Internal medicine, Internal Medicine, medicine, Animals, Humans, Myocytes, Cardiac, Autocrine signalling, Receptor, [SDV.BC] Life Sciences [q-bio]/Cellular Biology, ComputingMilieux_MISCELLANEOUS, Pressure overload, endoglin, biology, [SDV.OT] Life Sciences [q-bio]/Other [q-bio.OT], Chemistry, Neuropeptides, Endoglin, medicine.disease, Activins, [SDV] Life Sciences [q-bio], 030104 developmental biology, Endocrinology, Cytokine, Heart failure, biology.protein, ComputingMethodologies_DOCUMENTANDTEXTPROCESSING, activin A, Endothelium, Vascular, hypertrophy, cardiomyopathy, Follistatin, Signal Transduction

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18b0c60549022e3b0cebe31fb792e09cTest
https://hal.archives-ouvertes.fr/hal-03439191Test

المؤلفون: Canan G. Nebigil, Laurent Désaubry, Anais Audebrand

المساهمون: Laboratoire de Cardio-Oncologie et Chimie Médicinale, Centre National de la Recherche Scientifique (CNRS), Nanomédecine Régénérative (NanoRegMed), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: Frontiers in Cardiovascular Medicine, Vol 6 (2020)
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine, Frontiers Media, 2020, 6, pp.194. ⟨10.3389/fcvm.2019.00194⟩
Frontiers in Cardiovascular Medicine, Frontiers Media, 2020, 6, ⟨10.3389/fcvm.2019.00194⟩

مصطلحات موضوعية: 0301 basic medicine, lcsh:Diseases of the circulatory (Cardiovascular) system, Myocarditis, Aucun, cardiotoxicity, [SDV.CAN]Life Sciences [q-bio]/Cancer, melatonin, Review, 030204 cardiovascular system & hematology, Pharmacology, Cardiovascular Medicine, GPCRs, 03 medical and health sciences, cannabidiol, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Medicine, Doxorubicin, Cardioprotective Agent, Adverse effect, ComputingMilieux_MISCELLANEOUS, Cardiotoxicity, galanin, business.industry, medicine.disease, Prokineticin, 3. Good health, Apelin, prokineticin, 030104 developmental biology, Drug development, apelin, lcsh:RC666-701, ghrelin, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, business, Cardiology and Cardiovascular Medicine, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7557d7b7bac4476e427a3151ec04c901Test
https://www.frontiersin.org/article/10.3389/fcvm.2019.00194/fullTest